Back to Search Start Over

Dok2 likely down-regulates Klf1 in mouse erythroleukemia cells.

Authors :
Tanaka Y
Kulkeaw K
Inoue T
Tan KS
Nakanishi Y
Shirasawa S
Sugiyama D
Source :
Anticancer research [Anticancer Res] 2014 Aug; Vol. 34 (8), pp. 4561-7.
Publication Year :
2014

Abstract

Background/aim: Docking protein 2 (Dok2) is an adapter protein which is involved in hematopoiesis. However, it still remains unclear how Dok2 functions in regulation of transcription of hematopoietic genes. To address this issue, we knocked-down Dok2 mRNA in mouse erythroleukemia cells which highly express Dok2 intrinsically.<br />Materials and Methods: Mouse erythroleukemia cells were transfected with Dok2 siRNA for 24 h and gene expression of erythroid differentiation-related genes, such as GATA binding protein 1 (Gata1), Krüppel-like factor 1 (Klf1), α-globin and β-globin were assessed by real-time polymerase chain reaction.<br />Results: Among the tested genes, expression of Klf1 exhibited a 1.94-fold increase when compared to the control 24 h after transfection. Immunocytochemistry and chromatin immunoprecipitation assays revealed that Dok2 protein localizes in the nucleus and binds to the promoter region of Klf1 gene.<br />Conclusion: Dok2 is able to control Klf1 expression by transcriptional regulation through directly binding to its promoter region.<br /> (Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.)

Details

Language :
English
ISSN :
1791-7530
Volume :
34
Issue :
8
Database :
MEDLINE
Journal :
Anticancer research
Publication Type :
Academic Journal
Accession number :
25075100